Glaxosmithkline Pharma trades in green on the BSE
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Glaxosmithkline Pharmaceuticals is currently trading at Rs. 1407.65, up by 2.35 points or 0.17% from its previous closing of Rs. 1405.30 on the BSE.
The scrip opened at Rs. 1405.00 and has touched a high and low of Rs. 1415.20 and Rs. 1404.00 respectively. So far 1190 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1917.00 on 13-Dec-2021 and a 52 week low of Rs. 1372.80 on 04-Aug-2022.
Last one week high and low of the scrip stood at Rs. 1440.65 and Rs. 1400.00 respectively. The current market cap of the company is Rs. 23872.70 crore.
The promoters holding in the company stood at 75.00%, while Institutions and Non-Institutions held 12.81% and 12.19% respectively.
Life Insurance Corporation of India (LIC) had offloaded 34.63 lakh equity shares or 2.04 percent stake in Glaxosmithkline Pharmaceuticals via open market transactions. With this, LIC's shareholding in the company reduced to 4.35 percent, down from 6.4 percent earlier.
GlaxoSmithKline Pharmaceuticals is an Indian subsidiary of GlaxoSmithKline plc. The company business has a broad portfolio of innovative and established medicines, with leadership positions in respiratory and HIV.
